ADMA Past Earnings image   This ADMA past earnings page last updated 11/22/2024
ADMA Past Earnings
PeriodPast Earnings DateGAAP
Q3 202411/7/20240.150
Q2 20248/8/20240.130
Q1 20245/9/20240.080
Q4 20232/28/20240.040
Q3 202311/8/20230.010
Q2 20238/9/2023-0.030
Q1 20235/10/2023-0.030
Q4 20223/23/2023-0.060
Q3 202211/9/2022-0.080
Q2 20228/10/2022-0.070
Q1 20225/11/2022-0.100
Q4 20213/24/2022-0.090
Q3 202111/10/2021-0.130
Q2 20218/11/2021-0.140
Q1 20215/12/2021-0.160
Q4 20203/25/2021-0.210
Q3 202011/5/2020-0.190
Q2 20208/5/2020-0.230
Q1 20205/6/2020-0.260
Q4 20193/12/2020-0.180
Q3 201911/6/2019-0.190
Q2 20198/8/2019-0.250
Q1 20195/8/2019-0.280
Q4 20183/13/2019-0.39
Q3 201811/8/2018-0.33
Q2 20188/10/2018-0.35
Q1 20185/14/2018-0.39
Q4 20173/5/2018-0.24
Q3 201711/3/2017-0.59
Q2 20178/11/2017-0.55
Q1 20175/12/2017-0.51
Q4 20162/24/2017-0.35
Q3 201611/10/2016-0.34
ADMA Past Revenue
PeriodPast Earnings DateGAAP
Q3 202411/7/20240.12B
Q2 20248/8/20240.11B
Q1 20245/9/20240.08B
Q4 20232/28/20240.07B
Q3 202311/8/20230.07B
Q2 20238/9/20230.06B
Q1 20235/10/20230.06B
Q4 20223/23/20230.05B
Q3 202211/9/20220.04B
Q2 20228/10/20220.03B
Q1 20225/11/20220.03B
Q4 20213/24/20220.03B
Q3 202111/10/20210.02B
Q2 20218/11/20210.02B
Q1 20215/12/20210.02B
Q4 20203/25/20210.01B
Q3 202011/5/20200.01B
Q2 20208/5/20200.01B
Q1 20205/6/20200.01B
Q4 20193/12/20200.01B
Q3 201911/6/20190.01B
Q2 20198/8/20190.01B
Q1 20195/8/20190.00B
Q4 20183/13/20194.06M
Q3 201811/8/20184.23M
Q2 20188/10/20184.66M
Q1 20185/14/20184.04M
Q4 20173/5/201812.00M
Q3 201711/3/20174.73M
Q2 20178/11/20173.40M
Q1 20175/12/20172.63M
Q4 20162/24/20173.33M
Q3 201611/10/20162.94M
Quotes delayed 20 minutes

Email EnvelopeFree ADMA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ADMA Biologics (ADMA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ADMP Past Earnings
ADMS Past Earnings
ADPT Past Earnings
ADTX Past Earnings
ADUS Past Earnings
ADVM Past Earnings
ADXS Past Earnings
AEMD Past Earnings
AERI Past Earnings
AFIB Past Earnings

ADMA Past Earnings Q&A

What was the best and worst ADMA past earnings results?
For ADMA Biologics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ADMA past earnings result in our data set was 0.150/share posted in Q3 2024, while the lowest was in Q3 2017 when ADMA posted -0.59/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2024 when ADMA reported 0.12B in revenue, while the quarter with the lowest revenue in our data set was Q1 2017 at 2.63M of revenue.

  Suggested answer: There are 33 ADMA past earnings results in our data set.

On this page we presented the ADMA past earnings date information for ADMA Biologics. Reviewing that ADMA Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2024, when ADMA posted gaap of 0.150/share. Meanwhile the lowest ADMA past earnings result was in Q3 2017, when ADMA posted gaap of -0.59/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2024 when ADMA reported 0.12B in revenue, while the smallest revenue quarter was Q1 2017 when ADMA reported 2.63M in revenue.

Any self directed investor doing their due diligence on ADMA or any other given stock can benefit from researching all of the ADMA Biologics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate ADMA Biologics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ADMA. Thanks for visiting, and the next time you need to research ADMA past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of JHMB, DUG YTD Return, Funds Holding AFTY.

 

ADMA Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.